Product Information
Febuxostat-D9 is a drug that inhibits the production of uric acid. It is used to treat hyperuricaemia, which can lead to gout or kidney stones. Febuxostat-D9 is a bioequivalent drug with an analytical method that uses high-performance liquid chromatography with mass spectrometry detection (LC-MS/MS). The LC-MS/MS method uses acetonitrile as a mobile phase and has been validated for use in pharmacokinetic studies. The validation process was done using a reversed-phase high-performance liquid chromatography with reaction monitoring.
Chemical properties
Technical inquiry about: 3D-WZB81950 Febuxostat-D9
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
